Picton Mahoney Asset Management’s BioPlus Acquisition Corp. Warrants BIOSW Stock Holding History

Picton Mahoney Asset Management’s Portfolio BIOSW Stock Details BIOSW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-75,000	Closed	-$4K	–	556
2023 Q3	$4K	Hold	75,000	–	–	﹤0.01%	396
2023 Q2	$10K	Hold	75,000	–	–	﹤0.01%	363
2023 Q1	$6K	Hold	75,000	–	–	﹤0.01%	453
2022 Q4	$4K	Hold	75,000	–	–	﹤0.01%	617
2022 Q3	$10K	Hold	75,000	–	–	﹤0.01%	631
2022 Q2	$10K	Hold	75,000	–	–	﹤0.01%	759
2022 Q1	$16K	Buy	+75,000	New	+$19.5K	﹤0.01%	867

Picton Mahoney Asset Management's BIOSW Position: Q4 2023 in Review

Picton Mahoney Asset Management sold out of BioPlus Acquisition Corp. Warrants (BIOSW) in Q4 2023, closing a stake of 75,000 shares — an estimated $4K sold.

Picton Mahoney Asset Management first reported a position in BIOSW in Q1 2022 and held it in 7 quarters. The position peaked at $16K in Q1 2022. 0 funds tracked by Wall St. Rank hold BIOSW as of Q4 2023.

Picton Mahoney Asset Management reported no remaining BioPlus Acquisition Corp. Warrants position as of Q4 2023 after selling out during the quarter.
Picton Mahoney Asset Management sold 75,000 BioPlus Acquisition Corp. Warrants shares in Q4 2023, an estimated $4K.
Picton Mahoney Asset Management first reported a position in BioPlus Acquisition Corp. Warrants in Q1 2022 and held it in 7 quarters.
Picton Mahoney Asset Management's BioPlus Acquisition Corp. Warrants position peaked at $16K in Q1 2022.
0 funds tracked by Wall St. Rank held BioPlus Acquisition Corp. Warrants as of Q4 2023.

Based on Picton Mahoney Asset Management's 13F filing for Q4 2023, filed 6 Feb 2024.